rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Nectar Lifesciences Ltd.

532649 NECLIFE Group (T)

04 Nov,15:29
39.74
0.63 (1.61%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Nectar Lifesciences Ltd.

BUYSELL
98,556 39.11 40.49 - 37.50 56.39 - 22.80 891.37
NSE | BSE

Nectar Lifesciences Ltd.

NECLIFE

04 Nov,15:47
39.69
0.71 (1.82%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Nectar Lifesciences Ltd.

BUYSELL
478,170 38.98 40.00 - 37.50 56.50 - 22.80 18,777,735.90
(Rs. Crore)

Financial Results of Nectar Lifesciences Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,685.631,524.611,668.261,542.902,363.16
Operating profit153.1155.66158.84110.23218.33
Interest87.1479.4878.81112.03125.82
Gross profit78.9918.4391.320.9296.51
EPS (Rs)0.22-1.001.13-3.261.34

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Nectar Lifesciences Ltd.

Nectar Lifesciences Limited is a pharmaceutical company in India that manufactures generic drug products. The company has global leadership in several oral and sterile cephalosporin drugs, and has cGMP facilities along with those approved by the European Union and Japan. Wikipedia

News for Pharmaceuticals and health care

Royal Enfield...
Royal Enfield Unveils Electric Bike Flying Flea C6 - 2026 Release
Royal Enfield enters the electric bike segment with the Flying Flea C6, a classic-styled model set to launch in 2026. Learn about their new EV brand, development, and future plans.
Nov 04, 2024 23:51
Sagility India...
Sagility India IPO: Rs 945 Cr Anchor Investor Funding
Sagility India, a healthcare tech services provider, raised Rs 945 crore from anchor investors ahead of its IPO, which opens on November 5th.
Nov 04, 2024 22:28
Sebi Demands Rs...
Sebi Demands Rs 130 Crore from 5 Entities in Reliance Home Fin Case
Sebi has issued demand notices to five entities, including Netizen Engineering and Citi Securities, for Rs 130 crore in connection with the illegal diversion of funds from Reliance Home Finance.
Nov 04, 2024 22:03
Suzuki Unveils...
Suzuki Unveils First Electric SUV: e Vitara
Suzuki launches its first mass-production battery electric vehicle, the e Vitara, in Europe. Production is set to begin in India in 2025 with global sales planned.
Nov 04, 2024 21:26
In-flight WiFi...
In-flight WiFi Access: New Rules Clarify Device Usage
India's new aviation rules clarify that in-flight WiFi is only available when electronic devices are permitted. Learn about the new regulations and their impact on passenger connectivity.
Nov 04, 2024 19:54

More News »

Top News

Royal Enfield...
Royal Enfield Unveils Electric Bike Flying Flea C6 - 2026 Release
Royal Enfield enters the electric bike segment with the Flying Flea C6, a classic-styled model set to launch in 2026. Learn about their new EV brand, development, and future plans.
Nov 04, 2024 23:51
Sagility India...
Sagility India IPO: Rs 945 Cr Anchor Investor Funding
Sagility India, a healthcare tech services provider, raised Rs 945 crore from anchor investors ahead of its IPO, which opens on November 5th.
Nov 04, 2024 22:28
Sebi Demands Rs...
Sebi Demands Rs 130 Crore from 5 Entities in Reliance Home Fin Case
Sebi has issued demand notices to five entities, including Netizen Engineering and Citi Securities, for Rs 130 crore in connection with the illegal diversion of funds from Reliance Home Finance.
Nov 04, 2024 22:03
Suzuki Unveils...
Suzuki Unveils First Electric SUV: e Vitara
Suzuki launches its first mass-production battery electric vehicle, the e Vitara, in Europe. Production is set to begin in India in 2025 with global sales planned.
Nov 04, 2024 21:26
FSIB Recommends Rahul Bhave for IFCI MD Post
FSIB has recommended Rahul Bhave, currently Deputy Managing Director of IFCI, for the position of Managing Director and CEO of IFCI Ltd. The final decision will be taken by the Appointments...
Nov 04, 2024 21:14

More Top News »

Report Card

PE Ratios
178.18
EPS (Rs.)
0.22
Sales (Rs. Cr)
359.30
Face Value (Rs.)
1
Net Profit Margin (%)
0.29
Last Bonus
Last Dividend(%)
5
Return on Average Equity
0.46

BSE Announcements from Nectar Lifesciences Ltd. (See all)

announcement Board Meeting Intimation for Financial Results For The Quarter And Half Year Ended On September 30, 2024 And Other Business Matters. - 1 day(s) ago
announcement Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations 2015. - 21 Oct 2024

Compare 'Nectar Lifesciences Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,858.70
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,207.70
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,004.00
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,036.65
  • Compare
  • Max Healthcare Institute Ltd.
  • 1,006.75
  • Compare
  • Divi's Laboratories Ltd.
  • 5,901.00
  • Compare
  • Alkem Laboratories Ltd.
  • 5,807.75
  • Compare

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I have hdfc small cap, multicap, flexicap funds all...

Hi I am 44 years old and have 5 cr in FD,s , 1.5 cr...

I was running a bussiness from last seven year with...

sir,A Doctor running a two hospitals . 2 nd hospital...

Hello Sir,Kindly review my mutual fund...

I am 44 years old and will retire at age of 58 yrs....

More REDIFFGURUS

RediffGurus

Money question

Thanks Sanjeev Sir for providing help to forces...

Nectar Lifesciences Ltd. performance snapshot

If you had invested Rs.  in Nectar Lifesciences Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Nectar Lifesciences Ltd.
Share Price » Fundamentals » Financial » Technicals » Screener » Open Demat »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Nectar Lifesciences Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Nectar Lifesciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close